BeStock  
Stocks › Biotechnology › OLMA

Olema Pharmaceuticals OLMA

US equityMarket cap rank #3472Biotechnology
$7.02 −$0.13 (-1.82%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $7.02 0.00%
Open$7.01
Prev close$7.15
Day range$6.88 – $7.36
Volume1.26M
Market cap$615.00M
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership121.0%-0.39 pts vs. prior quarter
Institutions holding226-2 vs. prior quarter
Insider trades (recent)23 buys / 25 sellsNet selling
Short interest19.57% of floatDays to cover 11.9 · as of 30 Oct 2026
Short-sale volume share21.2%5-day average of daily volume

Short-sale volume as % of daily volume

12%19%25%32%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$495.2K (13 inflow days, 7 outflow days).

Net flow by order size, last 20 sessions

−$1.5MSuper+$1.0MBig−$1.1MMid−$230.2KSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 47.3% of shares outstanding.

Largest holders

  • FMR13.07%
  • Paradigm Biocapital Advisors LP9.90%
  • BlackRock8.20%
  • Janus Henderson Group plc8.10%
  • Bain Capital Life Sciences Investors, LLC8.09%
  • BVF Partners L.P.6.05%
  • Artal Group S.A.5.54%
  • State Street Global Advisors4.40%

By investor type

  • Mutual Fund61.90%
  • Hedge Fund33.89%
  • VC/PE Fund17.66%
  • Public Company5.18%
  • Individual/Insider2.68%
  • Family Office/Trust1.18%
  • Private Company0.60%
  • Government Pension Fund0.38%

Reported short interest has risen from 18.07% to 19.57% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Morgan Stanley Public Company 2026/Q3 +546,285 2.7%
Morgan Stanley Investment Management Inc. Mutual Fund 2026/Q3 +546,285 2.7%
BlackRock Mutual Fund 2026/Q3 +466,649 8.2%
Candriam, Société En Commandite Par Actions Mutual Fund 2026/Q3 +433,334 1.4%
Vanguard Capital Management, LLC Mutual Fund 2026/Q3 +171,976 4.0%
Deka Investment GmbH Mutual Fund 2026/Q3 +160,000 0.2%
Geode Capital Management, LLC Mutual Fund 2026/Q3 +150,880 2.2%
Dimensional Fund Advisors Mutual Fund 2026/Q3 +136,304 1.8%
Y-Intercept (Hong Kong) Limited Mutual Fund 2026/Q3 +101,658 0.1%
FMR Mutual Fund 2026/Q3 +1,756,257 13.9%
Deep Track Capital, LP VC/PE Fund 2026/Q3 +1,500,000 1.7%
Franklin Resources Mutual Fund 2026/Q3 +1,130,857 2.7%
Vanguard Portfolio Management, LLC Mutual Fund 2026/Q3 +1,070,187 1.9%
BlackRock Mutual Fund 2026/Q3 +1,062,556 7.7%
Point72 Asset Management, L.P. Hedge Fund 2026/Q3 +999,842 1.2%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
31 Aug 2026 Jason O'Byrne Other Derivative Acquisition +650,000 $10.56 650,000
23 Jul 2026 Cyrus Harmon Independent Director Intent to Sell (Form 144) -12,500 $11.71 –
23 Jul 2026 Cyrus Harmon Independent Director Open Market Disposition -25,000 $11.71 819,798
22 Jul 2026 Cyrus Harmon Independent Director Intent to Sell (Form 144) -12,500 $11.58 –
17 Jun 2026 Andrew Rappaport Independent Director Other Derivative Acquisition +29,500 $9.51 29,500
17 Jun 2026 Cynthia Butitta Independent Director Other Derivative Acquisition +29,500 $9.51 29,500
17 Jun 2026 Ian T. Clark Independent Chairperson of the Board Other Derivative Acquisition +29,500 $9.51 29,500
17 Jun 2026 BVF Partners L.P. Other Derivative Acquisition +29,500 $9.51 29,500
17 Jun 2026 Sandra Horning Independent Director Other Derivative Acquisition +29,500 $9.51 29,500
17 Jun 2026 Scott Garland Independent Director Other Derivative Acquisition +29,500 $9.51 29,500
17 Jun 2026 Graham L. Walmsley Independent Director Other Derivative Acquisition +29,500 $9.51 29,500
17 Jun 2026 Yi Larson Independent Director Other Derivative Acquisition +29,500 $9.51 29,500
17 Jun 2026 Prakash Raman Independent Director Other Derivative Acquisition +29,500 $9.51 29,500
17 Jun 2026 Gorjan Hrustanovic Former Independent Director Other Derivative Acquisition +29,500 $9.51 29,500
17 Jun 2026 Cyrus Harmon Independent Director Other Derivative Acquisition +29,500 $9.51 29,500
27 Apr 2026 Prakash Raman Independent Director Other Derivative Acquisition +27,061 $14.59 24,150
15 Mar 2026 Shane William Kovacs Former Chief Operating & Financial Officer Intent to Sell (Form 144) -100,000 $16.08 –
15 Mar 2026 Shane William Kovacs Former Chief Operating & Financial Officer Intent to Sell (Form 144) -4,166 $16.61 –
10 Mar 2026 Shane William Kovacs Former Chief Operating & Financial Officer Intent to Sell (Form 144) -50,000 $15.94 –
9 Mar 2026 Shane William Kovacs Former Chief Operating & Financial Officer Intent to Sell (Form 144) -53,206 $17.00 –

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 17,124,622 19.6% 11.9
15 Oct 2026 15,678,877 17.9% 13.4
30 Sep 2026 14,696,219 16.8% 10.2
15 Sep 2026 16,068,469 18.4% 15.9
31 Aug 2026 15,663,548 17.9% 18.5
14 Aug 2026 15,808,921 18.1% 14.3

Discussion

No comments yet — be the first to weigh in on OLMA.

Sign in to join the discussion.

Scroll to Top